Fanconi anemia (FA) is a rare multigenic chromosomal instability syndrome that predisposes patients to life-threatening bone marrow failure, congenital malformations, and cancer. Functional loss of interstrand cross-link (ICL) DNA repair system is held responsible, though the mechanism is not yet fully understood. The clinical and molecular findings of 20 distinct FA cases, ages ranging from perinatal stage to 32 years, are presented here. Pathogenic variants in FANCA were found responsible in 75%, FANCC, FANCE, FANCJ/BRIP1, FANCL in 5%, and FANCD1/BRCA2 and FANCN/PALB2 in 2.5% of the subjects. Altogether, 25 different variants in 7 different FA genes, including 10 novel mutations in FANCA, FANCN/PALB2, FANCE, and FANCJ/BRIP1, were disclosed. Two compound heterozygous germline cases were mosaic for one allele, revealing that the incidence of reverse mutations may not be uncommon in FA. Another case with de novo FANCD1/BRCA2 and paternally inherited FANCN/PALB2 pathogenic alleles at first glance suggested a digenic inheritance, because the presence of a second pathogenic variant in the unexamined regions of FANCD1/BRCA2 and FANCN/PALB2 were exluded by sequencing and deletion/duplication analysis. A better understanding of the complexity of the FA genotype may provide further access to undiscovered ICL components and apparently dispensable cellular pathways where FA proteins may play important roles.

1.
Acuna-Hidalgo
R
,
Veltman
JA
,
Hoischen
A
.
New insights into the generation and role of de novo mutations in health and disease
.
Genome Biol
.
2016
;
17
(
1
):
241
.
2.
Adzhubei
I
,
Jordan
DM
,
Sunyaev
,
SR
.
Predicting functional effect of human missense mutations using PolyPhen-2
.
Curr Protoc Hum Genet
.
2013
;
Chapter 7
(
1
):
Unit7
20
.
3.
Altay
C
,
Alikaşifoglu
M
,
Kara
A
,
Tunçbilek
E
,
Özbek
N
,
Schroeder-Kurth
TM
.
.
Analysis of 65 Turkish patients with congenital aplastic anemia (Fanconi anemia and non-Fanconi anemia): Hacettepe experience
.
Clin Genet
.
1997
;
51
(
5
):
296
302
.
4.
Alter
BP
.
Fanconi anemia and the development of leukemia
.
Best Pract Res Clin Haematol
.
2014
;
27
(
3-4
):
214
21
.
5.
Alter
BP
,
Giri
N
.
Thinking of VACTERL-H? Rule out Fanconi Anemia according to PHENOS
.
Am J Med Genet A
.
2016
;
170
(
6
):
1520
4
.
6.
Ameziane
N
,
May
P
,
Haitjema
A
,
van de Vrugt
HJ
,
van Rossum-Fikkert
SE
,
Ristic
D
,
.
A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51
.
Nat Commun
.
2015
;
6
(
1
):
8829
.
7.
Balta
G
,
de Winter
JP
,
Kayserili
H
,
Pronk
JC
,
Joenje
H
,
Joenje
H
.
Fanconi anemia A due to a novel frameshift mutation in hotspot motifs: lack of FANCA protein
.
Hum Mutat
.
2000
;
15
(
6
):
578
.
8.
Auerbach
Arleen D
.
Fanconi anemia and its diagnosis.
.
Mutat. Res.
, 0027-5107
2009
;
668
(
1–2
):
4
10
. doi:.
[PubMed]
.
9.
Balta
G
,
Patiroglu
T
,
Gumruk
F
.
Fanconi Anemia and Ataxia telangiectasia in siblings who inherited unique combinations of novel FANCA and ATM null mutations
.
J Pediatr Hematol Oncol
.
2019
;
41
(
3
):
243
6
.
10.
Beşpınar
FU
,
Beşpınar
LZ
.
Türkiye’de hane halki yapilari ve evlilik pratiklerinde ikili resim: geleneklerin yani sira değişimin yansimalari
.
Nufusbil Derg
.
2017
;
39
(
1
):
109
49
.
11.
Castella
M
,
Pujol
R
,
Callén
E
,
Trujillo
JP
,
Casado
JA
,
Gille
H
,
.
Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations
.
Blood
.
2011
;
117
(
14
):
3759
69
.
12.
Castilla
LH
,
Couch
FJ
,
Erdos
MR
,
Hoskins
KF
,
Calzone
K
,
Garber
JE
,
.
Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer
.
Nat Genet
.
1994
;
8
(
4
):
387
91
.
13.
Ceccaldi
R
,
Sarangi
P
,
D'Andrea
AD
.
The Fanconi anaemia pathway: new players and new functions
.
Nat Rev Mol Cell Biol
.
2016
;
17
(
6
):
337
49
.
14.
Chandra
S
,
Levran
O
,
Jurickova
I
,
Maas
C
,
Kapur
R
,
Schindler
D
,
.
A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients
.
Mol Ther
.
2005
;
12
(
5
):
976
84
.
15.
Coffa
J
,
Van Den Berg
J
.
Analysis of MLPA data using novel software Coffalyser.NET by MRC-Holland. Modern approaches to quality control
.
Rijeka, Croatia: InTech
.
2011
125
50
.
16.
Datta
A
,
Brosh Jr.
RM
.
Holding all the cards - How fanconi anemia proteins deal with replication stress and preserve genomic stability
.
Genes
.
2019
;
10
(
2
):
170
.
17.
Davies
SM
,
Radloff
GA
,
DeFor
TE
,
Levran
O
,
Batish
SD
,
Hanenberg
H
,
.
GST genotype may modify clinical phenotype in patients with Fanconi anaemia
.
Br J Haematol
.
2005
;
131
(
1
):
118
22
.
18.
De Bont
R
,
Van Larebeke
N
.
Endogenous DNA damage in humans: a review of quantitative data
.
Mutagenesis
.
2004
;
19
(
3
):
169
85
.
19.
Deans
AJ
,
West
SC
.
DNA interstrand crosslink repair and cancer
.
Nat Rev Cancer
.
2011
;
11
(
7
):
467
80
.
20.
den Dunnen
JT
,
Dalgleish
R
,
Maglott
DR
,
Hart
RK
,
Greenblatt
MS
,
McGowan-Jordan
J
,
.
HGVS recommendations for the description of sequence variants: 2016 update
.
Hum Mutat
.
2016
;
37
(
6
):
564
9
.
21.
Desmet
FO
,
Hamroun
D
,
Lalande
M
,
Collod-Béroud
G
,
Claustres
,
M
,
Béroud
C
.
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
.
Nucleic Acids Res
.
2009
;
37
(
9
):
e67
e67
.
22.
Dong
Y
,
Hakimi
MA
,
Chen
X
,
Kumaraswamy
E
,
Cooch
NS
,
Godwin
AK
,
.
Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair
.
Mol Cell
.
2003
;
12
(
5
):
1087
99
.
23.
Dubois
EL
,
Guitton-Sert
L
,
Béliveau
M
,
Parmar
K
,
Chagraoui
J
,
Vignard
J
,
.
A Fanci knockout mouse model reveals common and distinct functions for FANCI and FANCD2
.
Nucleic Acids Res
.
2019
;
47
(
14
):
7532
47
.
24.
Eiler
ME
.
Fanconi Anemia: Guidelines for Diagnosis and Management
:
Fanconi Anemia Research Fund
.
2008
25.
Esmailnia
G
,
Fadaee
M
,
Royer
R
,
Dehghan
K
,
Akbari
MR
Profiling Fanconi Anemia Gene Mutations Among Iranian Patients
,
19(4)
.
Arch Iran Med.
;
2016.
. p.
236
240
.
26.
Esmer
C
,
Sánchez
S
,
Ramos
S
,
Molina
B
,
Frias
S
,
Carnevale
A
.
DEB test for Fanconi anemia detection in patients with atypical phenotypes
.
Am J Med Genet A
.
2004
;
124A
(
1
):
35
9
.
27.
Fargo
JH
,
Rochowski
A
,
Giri
N
,
Savage
SA
,
Olson
SB
,
Alter
BP
.
Comparison of chromosome breakage in non-mosaic and mosaic patients with Fanconi anemia, relatives, and patients with other inherited bone marrow failure syndromes
.
Cytogenet Genome Res
.
2014
;
144
(
1
):
15
27
.
28.
Gille
JJ
,
Floor
K
,
Kerkhoven
L
,
Ameziane
N
,
Joenje
H
,
de Winter
JP
.
Diagnosis of Fanconi anemia: mutation analysis by multiplex ligation-dependent probe amplification and PCR-based Sanger sequencing
.
Anemia
.
2012
;
2012
:
603253
.
29.
Gregory
JJ
,
Wagner
JE
,
Verlander
PC
,
Levran
O
,
Batish
SD
,
Eide
CR
,
.
Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells
.
Proc Natl Acad Sci USA
.
2001
;
98
(
5
):
2532
7
.
30.
Gross
M
,
Hanenberg
H
,
Lobitz
S
,
Friedl
R
,
Herterich
S
,
Dietrich
R
,
.
Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction
.
Cytogenet Genome Res
.
2002
;
98
(
2-3
):
126
35
.
31.
Hartford
SA
,
Chittela
R
,
Ding
X
,
Vyas
A
,
Martin
B
,
Burkett
S
,
.
Interaction with PALB2 is essential for maintenance of genomic integrity by BRCA2
.
PLoS Genet
.
2016
;
12
(
8
):
e1006236
.
32.
Higgs
MR
,
Reynolds
JJ
,
Winczura
A
,
Blackford
AN
,
Borel
V
,
Miller
ES
,
.
BOD1L is required to suppress deleterious resection of stressed replication forks
.
Mol Cell
.
2015
;
59
(
3
):
462
77
.
33.
Hlavin
EM
,
Smeaton
MB
,
Noronha
AM
,
Wilds
CJ
,
Miller
PS
.
Cross-link structure affects replication-independent DNA interstrand cross-link repair in mammalian cells
.
Biochemistry
.
2010
;
49
(
18
):
3977
88
.
34.
Howlett
NG
,
Taniguchi
T
,
Durkin
SG
,
D'Andrea
AD
,
Glover
TW
.
The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability
.
Hum Mol Genet
.
2005
;
14
(
5
):
693
701
.
35.
Itan
Y
,
Shang
L
,
Boisson
B
,
Ciancanelli
MJ
,
Markle
JG
,
Martinez-Barricarte
R
,
.
The mutation significance cutoff: gene-level thresholds for variant predictions
.
Nat Methods
.
2016
;
13
(
2
):
109
10
.
36.
Kalb
R
,
Neveling
K
,
Nanda
I
,
Schindler
D
,
Hoehn
H
.
Fanconi anemia: causes and consequences of genetic instability
,
Genome Dyn
, in Volff JN (ed):
Genome and Disease
.
Karger Publishers
, Basel,
2006
;
1
:
218
42
.
37.
Karczewski
KJ
,
Francioli
LC
,
Tiao
G
,
Cummings
BB
,
Alföldi
J
,
Wang
Q
,
.
Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes
.
bioRxivorg
.
2019
;
531210.
.
38.
Kennedy
RD
,
D'Andrea
AD
.
The Fanconi Anemia/BRCA pathway: new faces in the crowd
.
Genes Dev
.
2005
;
19
(
24
):
2925
40
.
39.
Knies
K
,
Inano
S
,
Ramírez
MJ
,
Ishiai
M
,
Surrallés
J
,
Takata
M
,
.
Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia
.
J Clin Invest
.
2017
;
127
(
8
):
3013
27
.
40.
Knoch
J
,
Kamenisch
Y
,
Kubisch
C
,
Berneburg
M
.
Rare hereditary diseases with defects in DNA-repair
.
Eur J Dermatol
.
2012
;
22
(
4
):
443
55
.
41.
Kopanos
C
,
Tsiolkas
V
,
Kouris
A
,
Chapple
CE
,
Albarca Aguilera
M
,
Meyer
R
,
.
VarSome: the human genomic variant search engine
.
Bioinformatics
.
2019
;
35
(
11
):
1978
80
.
42.
Krainer
M
,
Silva-Arrieta
S
,
FitzGerald
MG
,
Shimada
A
,
Ishioka
C
,
Kanamaru
R
,
.
Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer
.
N Engl J Med
.
1997
;
336
(
20
):
1416
21
.
43.
Kumar
P
,
Henikoff
S
,
Ng
PC
.
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
.
Nat Protoc
.
2009
;
4
(
7
):
1073
81
.
44.
Kutler
DI
,
Singh
B
,
Satagopan
J
,
Batish
SD
,
Berwick
M
,
Giampietro
PF
,
.
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
.
Blood
.
2003
;
101
(
4
):
1249
56
.
45.
Landrum
MJ
,
Lee
JM
,
Benson
M
,
Brown
G
,
Chao
C
,
Chitipiralla
S
,
.
ClinVar: public archive of interpretations of clinically relevant variants
.
Nucleic Acids Res
.
2016
;
44
(
D1
):
D862
8
.
46.
Lobitz
S
,
Velleuer
E
.
Guido Fanconi (1892-1979): a jack of all trades
.
Nat Rev Cancer
.
2006
;
6
(
11
):
893
8
.
47.
Ly
D
,
Forman
D
,
Ferlay
J
,
Brinton
LA
,
Cook
MB
.
An international comparison of male and female breast cancer incidence rates
.
Int J Cancer
.
2013
;
132
(
8
):
1918
26
.
48.
Mota
MBS
,
Carvalho
MA
,
Monteiro
ANA
,
Mesquita
RD
.
DNA damage response and repair in perspective: Aedes aegypti, Drosophila melanogaster and Homo sapiens
.
Parasit Vectors
.
2019
;
12
(
1
):
1
20
.
49.
Nakamura
A
,
Matsuura
S
,
Tauchi
H
,
Hanada
R
,
Ohashi
H
,
Hasegawa
T
,
.
Four novel mutations of the Fanconi anemia group A gene (FAA) in Japanese patients
.
J Hum Genet
.
1999
;
44
(
1
):
48
51
.
50.
Navarro
S
,
Meza
NW
,
Quintana-Bustamante
O
,
Casado
JA
,
Jacome
A
,
McAllister
K
,
.
Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1
.
Mol Ther
.
2006
;
14
(
4
):
525
35
.
51.
Nikkilä
J
,
Christin Parplys
A
,
Pylkäs
K
,
Bose
M
,
Huo
Y
,
Borgmann
K
,
.
Heterozygous mutations in PALB2 cause DNA replication and damage response defects
.
Nat Commun
.
2013
;
4
(
1
):
2578
.
52.
Niraj
J
,
Färkkilä
A
,
D'Andrea
AD
.
The Fanconi anemia pathway in cancer
.
Annu Rev Cancer Biol
.
2019
;
3
:
457
78
.
53.
Noll
DM
,
Mason
TM
,
Miller
PS
.
Formation and repair of interstrand cross-links in DNA
.
Chem Rev
.
2006
;
106
(
2
):
277
301
.
54.
Palovcak
A
,
Liu
W
,
Yuan
F
,
Zhang
Y
.
Maintenance of genome stability by Fanconi anemia proteins
.
Cell Biosci
.
2017
;
7
(
1
):
8
.
55.
Park
J
,
Chung
NG
,
Chae
H
,
Kim
M
,
Lee
S
,
Kim
Y
,
.
FANCA and FANCG are the major Fanconi anemia genes in the Korean population
.
Clin Genet
.
2013
;
84
(
3
):
271
5
.
56.
Peffault de Latour
R
,
Porcher
R
,
Dalle
J
,
Aljurf
M
,
Korthof
ET
,
Svahn
J
, ,
FA Committee of the Severe Aplastic Anemia Working Party
;
Pediatric Working Party of the European Group for Blood and Marrow Transplantation
..
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience.
.
Blood
.
2013
;
122
(
26
):
4279
4286
. .
[PubMed]
.
57.
Richards
S
,
Aziz
N
,
Bale
S
,
Bick
D
,
Das
S
,
Gastier-Foster
J
,
.
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
.
Genet Med
.
2015
;
17
(
5
):
405
24
.
58.
Rizzolo
P
,
Silvestri
V
,
Tommasi
S
,
Pinto
R
,
Danza
K
,
Falchetti
M
,
.
Male breast cancer: genetics, epigenetics, and ethical aspects
.
Ann Oncol
.
2013
;
24
(
Suppl l_8
):
viii75
82
.
59.
Rosenberg
PS
,
Alter
BP
,
Ebell
W
.
Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry
.
Haematologica
.
2008
;
93
(
4
):
511
7
.
60.
Scheckenbach
K
,
Morgan
M
,
Filger-Brillinger
J
,
Sandmann
M
,
Strimling
B
,
Scheurlen
W
,
.
Treatment of the bone marrow failure in Fanconi anemia patients with danazol
.
Blood Cells Mol Dis
.
2012
;
48
(
2
):
128
31
.
61.
Schwab
RA
,
Nieminuszczy
J
,
Shah
F
,
Langton
J
,
Lopez Martinez
D
,
Liang
CC
,
.
The Fanconi anemia pathway maintains genome stability by coordinating replication and transcription
.
Mol Cell
.
2015
;
60
(
3
):
351
61
.
62.
Schwarz
JM
,
Cooper
DN
,
Schuelke
M
,
Seelow
D
.
MutationTaster2: mutation prediction for the deep-sequencing age
.
Nat Methods
.
2014
;
11
(
4
):
361
2
.
63.
Shimamura
A
,
Alter
BP
.
Pathophysiology and management of inherited bone marrow failure syndromes
.
Blood Rev
.
2010
;
24
(
3
):
101
22
.
64.
Shyamsunder
P
,
Esner
M
,
Barvalia
M
,
Wu
YJ
,
Loja
T
,
Boon
HB
,
.
Impaired mitophagy in Fanconi anemia is dependent on mitochondrial fission
.
Oncotarget
.
2016
;
7
(
36
):
58065
74
.
65.
Silvestri
V
,
Zelli
V
,
Valentini
V
,
Rizzolo
P
,
Navazio
AS
,
Coppa
A
,
.
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene
.
Cancer
.
2017
;
123
(
2
):
210
8
.
66.
Solomon
BD
,
Bear
KA
,
Kimonis
V
,
de Klein
A
,
Scott
DA
,
Shaw-Smith
C
,
.
Clinical geneticists' views of VACTERL/VATER association
.
Am J Med Genet A
.
2012
;
158A
(
12
):
3087
100
.
67.
Sumpter
R
,
Levine
B
.
Emerging functions of the Fanconi anemia pathway at a glance
.
J Cell Sci
.
2017
;
130
(
16
):
2657
62
.
68.
Waisfisz
Q
,
Morgan
NV
,
Savino
M
,
De Winter
JP
,
Van Berkel
CG
,
Hoatlin
ME
,
.
Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism
.
Nat Genet
.
1999
;
22
(
4
):
379
83
.
69.
Wegman‐Ostrosky
T
,
Savage
SA
.
The genomics of inherited bone marrow failure: from mechanism to the clinic
.
Br J Haematol
.
2017
;
177
(
4
):
526
42
.
70.
Wenzel
ES
,
Singh
ATK
:
Cell-cycle checkpoints and aneuploidy on the path to cancer
.
In Vivo
.
2018
;
32
(
1
):
1
5
.
71.
Wu
Z-H
.
The concept and practice of Fanconi Anemia: from the clinical bedside to the laboratory bench
.
Transl Pediatr
.
2013
;
2
(
3
):
112
9
.
72.
Xia
B
,
Sheng
Q
,
Nakanishi
K
,
Ohashi
A
,
Wu
J
,
Christ
N
,
.
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
,
Mol Cell
.
2006
;
22
(
6
):
719
29
.
73.
Zeman
MK
,
Cimprich
KA
.
Causes and consequences of replication stress
.
Nat Cell Biol
.
2014
;
16
(
1
):
2
9
.
74.
Zhang
F
,
Ma
J
,
Wu
J
,
Ye
L
,
Cai
H
,
Xia
B
,
.
PALB2 links BRCA1 and BRCA2 in the DNA-damage response
.
Curr Biol
.
2009
;
19
(
6
):
524
9
.
You do not currently have access to this content.